First Time Loading...
T

Talkmed Group Ltd
SGX:5G3

Watchlist Manager
Talkmed Group Ltd
SGX:5G3
Watchlist
Price: 0.4 SGD -1.23% Market Closed
Updated: May 7, 2024

Talkmed Group Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Talkmed Group Ltd
Cash from Financing Activities Peer Comparison

Comparables:
P8A
QC7
5NG
1B1
EUDA

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
T
Talkmed Group Ltd
SGX:5G3
Cash from Financing Activities
-S$31.7m
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Cordlife Group Ltd
SGX:P8A
Cash from Financing Activities
S$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Cash from Financing Activities
-S$32m
CAGR 3-Years
10%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Healthway Medical Corporation Ltd
SGX:5NG
Cash from Financing Activities
-S$12.5m
CAGR 3-Years
-13%
CAGR 5-Years
-53%
CAGR 10-Years
N/A
HC Surgical Specialists Ltd
SGX:1B1
Cash from Financing Activities
-S$6.1m
CAGR 3-Years
-6%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
EUDA Health Holdings Ltd
NASDAQ:EUDA
Cash from Financing Activities
$2.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Talkmed Group Ltd's Cash from Financing Activities?
Cash from Financing Activities
-31.7m SGD

Based on the financial report for Dec 31, 2023, Talkmed Group Ltd's Cash from Financing Activities amounts to -31.7m SGD.

What is Talkmed Group Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-6%

Over the last year, the Cash from Financing Activities growth was 6%. The average annual Cash from Financing Activities growth rates for Talkmed Group Ltd have been -10% over the past three years , -6% over the past five years .